Showing results (251-260 of 610) with videos related to
Sort By:
Pageof 61
Pharmacological Research|April 8, 2015
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized studyGianluca Campo, Rita Pavasini, Simone Biscaglia, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2012
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients?Gianluca Campo, Rita Pavasini, Alberto Pollina, et al.Recenti Progressi in Medicina|February 28, 2006
[Markers of coronary damage. From diagnosis to prognosis]Marco Valgimigli, Paolo A M Squasi, Stavroula Gaitani, et al.The New England Journal of Medicine|September 2, 2014
Ivabradine in stable coronary artery disease without clinical heart failureKim Fox, Ian Ford, Philippe Gabriel Steg, et al.Drugs|August 22, 2019
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying ApproachEnrico Fabris, Marco Merlo, Claudio Rapezzi, et al.Basic Research in Cardiology|April 11, 2020
COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm?Paola Rizzo, Francesco Vieceli Dalla Sega, Francesca Fortini, et al.The Journal of Biological Chemistry|June 22, 2006
A minimal promoter for TFIIIC-dependent in vitro transcription of snoRNA and tRNA genes by RNA polymerase IIIElisa Guffanti, Roberto Ferrari, Milena Preti, et al.Archives of Biochemistry and Biophysics|December 5, 2003
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stressMarco Valgimigli, Elisa Merli, Patrizia Malagutti, et al.Journal of Cardiology Cases|December 12, 2018
Enhanced stent visualization systems during PCI: A case series and review of literatureSimone Biscaglia, Carlo Tumscitz, Matteo Tebaldi, et al.Biologics : Targets & Therapy|August 27, 2009
Abciximab: a reappraisal of its use in coronary careMarco Valgimigli, Gianluca Campo, Matteo Tebaldi, et al.Pageof 61